WiCell is a prominent leader in the field of stem cell science, specializing in the banking and characterization of pluripotent stem cells. The company offers a diverse array of human pluripotent stem cell lines, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and genetically modified variants. WiCell's characterization services are comprehensive, featuring both non-GMP and cGMP karyotyping, Fluorescence in situ Hybridization (FISH), and authentication through Short Tandem Repeat (STR) profiling. Additionally, they provide Single Nucleotide Polymorphism (SNP) microarray analysis and mycoplasma testing, ensuring the integrity and reliability of their cell lines for research and clinical applications.

Beyond cell banking, WiCell is committed to advancing regenerative medicine and cell and gene therapy. Their WiCellSAFE program offers long-term liquid nitrogen storage for stem cells, while tailored services such as quality control testing and contract cell banking help laboratories optimize their resources. With a focus on quality, innovation, and collaboration, WiCell aims to support the scientific community in groundbreaking research and clinical applications, reflecting their dedication to promoting best practices in stem cell technology since their inception in 1999.

United States

As a recognized world leader in pluripotent stem cell banking and characterization, WiCell provides the stem cell community with high-quality cell lines as well as accurate and reliable cell characterization and cytogenetic testing services. We offer both cGMP and research grade services and cell lines to fit your lab's needs. In addition, WiCell offers affordable and reliable long-term LN2 storage through our WiCellSAFE program to safeguard and protect your research investment.

WiCell

Company Details